Safety, Tolerability, PK and PD of BI 655075 and Establishment of BI 655075 Dose(s) Effective to Reverse Prolongation of Blood Coagulation Time by Dabigatran
Clinical trial NCT01955720 · COMPLETED
Trial details
- NCT number
- NCT01955720
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-01
- Primary completion
- 2014-05-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.